• Username (E-mail)
  • Password
Dow 19,913 0.6%  EStoxx50 3,282 0.3%  Nikkei 18,788 -0.6%  EUR 1.0734 -0.3% 
Nasdaq 5,601 0.9%  FTSE100 7,150 0.0%  Yen 113.7880 1.0%  Oil 55.3 -0.1% 
S&P500 2,280 0.7%  DAX 11,595 0.4%  GBP 1.2516 -0.1%  Gold 1,210 -0.8% 

Intuitive Surgical share [Symbol: ISRG / ISIN: US46120E6023]

10/22/2012 07:11:36 AM
10/22/2012 07:11:36 AM UTC-0400

Intuitive Surgical Inc Buy

The analysts of Banc of America Securities-Merrill Lynch have rated Intuitive Surgical with a Buy rating. The price target was set to 20.00 $. At a current price of the Intuitive Surgical stock of 680.00 $ this means a downside potential of -97.06%.
Summary: Intuitive Surgical Inc Buy
Company:
Intuitive Surgical Inc
Analyst:
Banc of America Securities-Merrill Lynch
Price Target:
20.00 $
Current Rating:
Buy
Price*:
551.52 $
Distance to Target Price*:
-96.37%
Previous Rating:
Upgrade
Latest Price:
680.00 $
Distance Price Target:
-97.06%
Analyst Name::
-
P/E Ratio*:
34.1

Analyst Opinions for Intuitive Surgical Inc

More Analyst Opinions
  • All
  • Buy
  • Hold
  • Sell
11/20/12
Intuitive Surgical Stifel, Nicolaus & Co., Inc.
10/31/12
Intuitive Surgical Barrington Research
10/22/12
Intuitive Surgical Banc of America Securities-Merrill Lynch
10/18/12
Intuitive Surgical Raymond James Financial, Inc.
06/29/12
Intuitive Surgical Fuchsbriefe

Add or Edit Instrument

Related Stocks

Intuitive Surgical Inc 666.05 1.68% Intuitive Surgical Inc
Latest Analyst Opinions
01/23/17 TLG IMMOBILIEN Norddeutsche Landesbank (Nord/LB)
01/23/17 ABB JP Morgan Chase & Co.
01/23/17 Zurich Insurance Group JP Morgan Chase & Co.
01/23/17 Apple Bernstein Research
01/23/17 Novo Nordisk A-S (B) JP Morgan Chase & Co.
01/23/17 Sky UBS AG
01/23/17 Vodafone Group UBS AG
01/23/17 BT Group UBS AG
01/23/17 RHÖN-KLINIKUM Independent Research GmbH
01/23/17 Credit Suisse Morgan Stanley
01/23/17 Deutsche Bank Morgan Stanley
01/23/17 Intesa Sanpaolo JP Morgan Chase & Co.
01/23/17 HORNBACH Baumarkt Hauck & Aufhäuser Privatbankiers KGaA
01/23/17 RHÖN-KLINIKUM Commerzbank AG
01/23/17 NORMA Group Oddo Seydler Bank AG
01/23/17 Reckitt Benckiser Group Barclays Capital
01/23/17 Deutsche Bank Commerzbank AG
01/23/17 LOréal Barclays Capital
01/23/17 Diageo Barclays Capital
01/23/17 LVMH Moet Hennessy Louis Vuitton Deutsche Bank AG
01/23/17 Renault UBS AG
01/23/17 Continental UBS AG
01/23/17 Daimler UBS AG
01/23/17 adidas Deutsche Bank AG
01/23/17 AstraZeneca Deutsche Bank AG
01/23/17 CompuGroup Medical Baader Bank
01/23/17 Bechtle Baader Bank
01/23/17 Beiersdorf Barclays Capital
01/23/17 Henkel vz Barclays Capital
01/23/17 Unilever Barclays Capital
01/23/17 Unilever Barclays Capital
01/23/17 GlaxoSmithKline Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
01/23/17 Orange Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
01/23/17 BNP Paribas Deutsche Bank AG
01/23/17 Société Générale SA Deutsche Bank AG
01/23/17 zooplus Warburg Research
01/23/17 ASML Baader Bank
01/23/17 Novo Nordisk A-S (B) Kepler Cheuvreux
01/23/17 Vonovia Kepler Cheuvreux
01/23/17 AIXTRON Baader Bank
01/23/17 Anheuser-Busch InBev UBS AG
01/23/17 PUMA Deutsche Bank AG
01/23/17 Glencore UBS AG
01/23/17 BT Group UBS AG
01/23/17 Royal Dutch Shell (A) UBS AG
01/23/17 Eni UBS AG
01/23/17 LOréal UBS AG
01/23/17 PUMA JP Morgan Chase & Co.
01/23/17 Novo Nordisk A-S (B) Goldman Sachs Group Inc.
01/23/17 Hapag-Lloyd Aktiengesellschaft Goldman Sachs Group Inc.